Table 3.
Group | n | Liver weight (g) | t | P | Lung weight (g) | t | P | |
Control | 6 | 1.62 ± 0.39 | 0.45 ± 0.09 | |||||
A | KAI1-LipofectAMINE | 6 | 0.99 ± 0.21 | 2.661 | < 0.05 | 0.30 ± 0.09 | 3.181 | < 0.05 |
pCMV-KAI1 | 6 | 1.01 ± 0.27 | 2.295 | < 0.05 | 0.33 ± 0.09 | 2.291 | < 0.05 | |
Control | 6 | 1.62 ± 0.39 | 0.45 ± 0.09 | |||||
B | KAI1-LipofectAMINE | 6 | 1.69 ± 0.17 | 0.312 | > 0.05 | 0.38 ± 0.03 | 1.348 | > 0.05 |
pCMV-KAI1 | 6 | 1.46 ± 0.28 | 1.286 | > 0.05 | 0.36 ± 0.04 | 1.956 | > 0.05 |
P < 0.05 between KAI1 transfection and controls.